Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China flag China · Delayed Price · Currency is CNY
5.08
+0.01 (0.20%)
At close: Feb 27, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Pharmaceutical Distribution
103.92M119.58M93.00M134.70M105.05M
Pharmaceutical Distribution Growth
-13.09%28.57%-30.95%28.22%8.12%
Unallocated Other Operating Income
13.06M21.34M19.13M14.61M5.92M
Unallocated Other Operating Income Growth
-38.81%11.59%30.91%146.82%-70.15%
Pharmaceutical Manufacturing
668.99M739.21M753.60M1.05B1.44B
Pharmaceutical Manufacturing Growth
-9.50%-1.91%-28.31%-27.08%-15.21%
Service income
9.63M15.46M18.86M24.72M30.94M
Service income Growth
-37.73%-18.03%-23.69%-20.12%-25.88%
Total
795.60M895.59M884.59M1.23B1.58B
Total Growth
-11.17%1.24%-27.80%-22.63%-14.82%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
China
795.60M895.59M884.59M1.23B1.58B
China Growth
-11.17%1.24%-27.80%-22.63%-14.82%
Total
795.60M895.59M884.59M1.23B1.58B
Total Growth
-11.17%1.24%-27.80%-22.63%-14.82%
Source: S&P Global Market Intelligence.